Your session is about to expire
← Back to Search
Genomic Tumor Board Review for Cancer
Study Summary
This trialcompares the usual approach to cancer treatment with an enhanced approach that includes a team of experts to review and suggest treatment options based on genomic test results.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any opportunities for people to participate in this research at present?
"Affirmative. The relevant clinicaltrials.gov page implies that this experiment, which was initially published on August 22nd 2022, is still searching for participants. For the trial to be completed 1182 people need to enrol from two different sites."
How many individuals have participated in this trial thus far?
"Indeed, clinicaltrials.gov indicates that this trial is actively recruiting participants as of today. It was first listed on August 22nd 2022 and the last update was January 24th 2023. The study needs to enroll 1182 patients from 2 different medical centers."
Share this study with friends
Copy Link
Messenger